#	Pagina
attuale pagina	/open-h2020/projects/222858/index.html

Opendata, web and dolomites

LCxLCProt SIGNED

Comprehensive two-dimensional liquid chromatography for the characterization of protein biopharmaceuticals at the protein level

Total Cost €

EC-Contrib. €

Partnership

Views

LCxLCProt project word cloud

Explore the words cloud of the LCxLCProt project. It provides you a very rough idea of what is the project "LCxLCProt" about.

demonstrated explored capacity responsive manufacturing thermally correlated release protein approvals dramatic decade fractions orthogonality gradients temperature periods edge mechanisms globally stationary experiments pharmaceutical experts cutting chromatography mechanism exchange dimensions monoclonal ion bands trapping first drugs confidence phases drug dimension modulation quality difficult analyte market intact good reversed purity characterization applicable liquid heterogeneous peak biopharmaceuticals gmp structural pharmaceuticals purposes popular greatest preliminary compatible diseases dimensional lc molecules forecast separation parallel later assurance thermal antibodies elevated times temperatures accurate biologics biopharmaceutical total treatment

Project "LCxLCProt" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITEIT GENT Organization address address: SINT PIETERSNIEUWSTRAAT 25 city: GENT postcode: 9000 website: http://www.ugent.be contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Belgium [BE]
Total cost	89˙160 €
EC max contribution	89˙160 € (100%)
Programme	1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
Code Call	H2020-MSCA-IF-2018
Funding Scheme	MSCA-IF-EF-ST
Starting year	2020
Duration (year-month-day)	from 2020-01-01 to 2020-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	UNIVERSITEIT GENT UNIVERSITEIT GENT Organization address address: SINT PIETERSNIEUWSTRAAT 25 city: GENT postcode: 9000 website: http://www.ugent.be contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (GENT)	coordinator	89˙160.00

Map

Project objective

Protein biopharmaceuticals, which globally represent about 20 % of the total pharmaceutical market, are becoming increasingly popular in the treatment of various diseases. Experts forecast that over 50 % of new drug approvals in the next decade will be for biologics, especially monoclonal antibodies. Very accurate structural characterization and purity analysis is required during both the development of the new drugs, and later during manufacturing for quality control purposes. Biopharmaceutical protein molecules are very large and heterogeneous, which makes their characterization very difficult. The goal of this project is to develop novel methods for the characterization of protein biopharmaceuticals at the protein level based on comprehensive two-dimensional liquid chromatography (LC×LC). Two approaches will be explored: the use of reversed phase separation mechanism in both dimensions with parallel gradients, and application of thermally responsive stationary phases for thermal modulation of LC×LC fractions. Parallel gradients provide the greatest orthogonality when the separation mechanisms in both dimensions are correlated, and allow the use of short modulation periods, which together lead to a dramatic increase in peak capacity (as demonstrated in preliminary experiments). Thermally responsive stationary phases allow trapping of the analyte bands at elevated temperatures, and their release at low temperature. This is compatible with intact protein analysis, especially when ion exchange is used in the first dimension of the LC×LC system. It is expected that the research will result in new, cutting edge methods for the analysis and characterization of protein biopharmaceuticals that will be applicable under the good manufacturing practice (GMP) conditions, improving the quality assurance/quality control and increasing the confidence in the pharmaceuticals.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LCXLCPROT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LCXLCPROT" are provided by the European Opendata Portal: CORDIS opendata.